• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全关节置换术患者组织因子、凝血酶激活的纤溶抑制物及纤维蛋白原的失调

Dysregulation of Tissue Factor, Thrombin-Activatable Fibrinolysis Inhibitor, and Fibrinogen in Patients Undergoing Total Joint Arthroplasty.

作者信息

Wanderling Christopher, Liles Jeffrey, Finkler Elissa, Carlsgaard Peter, Hopkinson William, Guler Nil, Hoppensteadt Debra, Fareed Jawed

机构信息

1 Stritch School of Medicine, Loyola University of Chicago, Maywood, IL, USA.

2 Department of Orthopedics, Loyola University Medical Center, Maywood, IL, USA.

出版信息

Clin Appl Thromb Hemost. 2017 Nov;23(8):967-972. doi: 10.1177/1076029617700998. Epub 2017 Mar 27.

DOI:10.1177/1076029617700998
PMID:28345356
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6707720/
Abstract

Total joint arthroplasty (TJA) of the hip or knee (THA, TKA) has become an increasingly common procedure. While TJA is a successful treatment for individuals experiencing degenerative joint diseases, it is well known that one of the most common perioperative complications of TJA is deep venous thrombosis (DVT). To profile tissue factor (TF), microparticle-tissue factor (MP-TF), thrombin-activatable fibrinolysis inhibitor (TAFI), and fibrinogen levels in patients undergoing TJA to determine potential preexisting Hemostatic dysregulation. De-identified blood samples were obtained from patients undergoing TJA 1 day pre- and 1 day postprocedure. Plasma samples were analyzed using enzyme-linked immunosorbent assay kits for fibrinogen, TAFI, TF, and MP-TF; fibrinogen levels were also assessed using a clot-based activity assay. In comparison with healthy controls, there were significant increases of fibrinogen and MP-TF levels, while there were significant decreases in TF and TAFI levels in the preoperative and postoperative patients. Comparing the pre versus postoperative patients, no significant differences were found; interestingly, however, surgical intervention exacerbated the changes found in the preoperative samples compared to the controls. The results of this study confirm that patients undergoing TJA have preexisting alterations in the fibrinolytic system. Surgical intervention tended to exacerbate these changes. The alterations observed in this study may provide insight as to why TJA is associated with higher rates of DVT and thromboembolism.

摘要

髋或膝关节的全关节置换术(TJA,包括全髋关节置换术[THA]和全膝关节置换术[TKA])已成为越来越常见的手术。虽然TJA是治疗退行性关节疾病患者的一种成功方法,但众所周知,TJA最常见的围手术期并发症之一是深静脉血栓形成(DVT)。为了分析接受TJA患者的组织因子(TF)、微粒组织因子(MP-TF)、凝血酶激活的纤溶抑制物(TAFI)和纤维蛋白原水平,以确定潜在的既往存在的止血失调情况。从接受TJA的患者术前1天和术后1天获取去识别化的血样。使用酶联免疫吸附测定试剂盒分析血浆样本中的纤维蛋白原、TAFI、TF和MP-TF;纤维蛋白原水平也使用基于凝血的活性测定法进行评估。与健康对照相比,术前和术后患者的纤维蛋白原和MP-TF水平显著升高,而TF和TAFI水平显著降低。比较术前和术后患者,未发现显著差异;然而,有趣的是,与对照组相比,手术干预加剧了术前样本中发现的变化。本研究结果证实,接受TJA的患者存在纤溶系统的既往改变。手术干预往往会加剧这些变化。本研究中观察到的改变可能有助于解释为什么TJA与更高的DVT和血栓栓塞发生率相关。

相似文献

1
Dysregulation of Tissue Factor, Thrombin-Activatable Fibrinolysis Inhibitor, and Fibrinogen in Patients Undergoing Total Joint Arthroplasty.全关节置换术患者组织因子、凝血酶激活的纤溶抑制物及纤维蛋白原的失调
Clin Appl Thromb Hemost. 2017 Nov;23(8):967-972. doi: 10.1177/1076029617700998. Epub 2017 Mar 27.
2
Thrombin activatable fibrinolysis inhibitor (TAFI) polymorphisms and plasma TAFI levels measured with an ELISA insensitive to isoforms in patients with venous thromboembolic disease (VTD).
Thromb Haemost. 2006 Mar;95(3):585-6. doi: 10.1160/TH05-09-0620.
3
Fibrinolytic Dysregulation in Total Joint Arthroplasty Patients: Potential Clinical Implications.全关节置换术患者的纤维蛋白溶解失调:潜在的临床意义。
Clin Appl Thromb Hemost. 2016 May;22(4):372-6. doi: 10.1177/1076029615597060. Epub 2015 Jul 22.
4
Metabolic Syndrome and Deep Vein Thrombosis After Total Knee and Hip Arthroplasty.全膝关节和髋关节置换术后的代谢综合征与深静脉血栓形成
J Arthroplasty. 2016 Jun;31(6):1322-1325. doi: 10.1016/j.arth.2015.12.021. Epub 2015 Dec 19.
5
Thrombin-activatable fibrinolysis inhibitor antigen and TAFI activity in patients with APC resistance caused by factor V Leiden mutation.因因子V莱顿突变导致活化蛋白C抵抗的患者中凝血酶可激活纤溶抑制物抗原及TAFI活性
Thromb Res. 2002 Apr 1;106(1):59-62. doi: 10.1016/s0049-3848(02)00072-5.
6
Predictive value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio for acute deep vein thrombosis after total joint arthroplasty: a retrospective study.中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值对全关节置换术后急性深静脉血栓形成的预测价值:一项回顾性研究
J Orthop Surg Res. 2018 Feb 27;13(1):40. doi: 10.1186/s13018-018-0745-x.
7
Perioperative Factors and Their Effect on the Fibrinolytic System in Arthroplasty Patients.关节置换术患者围手术期因素及其对纤溶系统的影响
Clin Appl Thromb Hemost. 2016 Apr;22(3):274-9. doi: 10.1177/1076029615611251. Epub 2015 Oct 11.
8
Elevated d-Dimer Is Not Predictive of Symptomatic Deep Venous Thrombosis After Total Joint Arthroplasty.D - 二聚体升高不能预测全关节置换术后症状性深静脉血栓形成。
J Arthroplasty. 2016 Oct;31(10):2269-72. doi: 10.1016/j.arth.2016.02.059. Epub 2016 Mar 10.
9
Mild hyperhomocysteinemia is associated with increased TAFI levels and reduced plasma fibrinolytic potential.轻度高同型半胱氨酸血症与凝血酶激活的纤溶抑制物(TAFI)水平升高及血浆纤溶潜力降低有关。
J Thromb Haemost. 2008 Sep;6(9):1571-7. doi: 10.1111/j.1538-7836.2008.03070.x. Epub 2008 Jul 4.
10
[Evaluation of selected parameters of blood coagulation and the fibrinolysis system in patients undergoing total hip replacement].[全髋关节置换术患者凝血及纤维蛋白溶解系统相关参数评估]
Przegl Lek. 2002;59(7):502-8.

引用本文的文献

1
Proteomic profiling of serum in cats with naturally occurring degenerative joint disease and co-morbid conditions.对患有自然发生的退行性关节疾病及共病的猫的血清进行蛋白质组分析。
Front Pain Res (Lausanne). 2025 Feb 4;6:1501932. doi: 10.3389/fpain.2025.1501932. eCollection 2025.
2
Pneumatic Compression Combined with Standard Treatment after Total Hip Arthroplasty and Its Effects on Edema of the Operated Limb and on Physical Outcomes: A Pilot Clinical Randomized Controlled Study.全髋关节置换术后气压治疗联合标准治疗及其对术侧肢体水肿和身体结局的影响:一项临床随机对照试验的初步研究
J Clin Med. 2023 Jun 20;12(12):4164. doi: 10.3390/jcm12124164.
3
Inflammatory Biomarkers as Prognostic Factors of Acute Deep Vein Thrombosis Following the Total Knee Arthroplasty.炎症生物标志物作为全膝关节置换术后急性深静脉血栓形成的预后因素。
Medicina (Kaunas). 2022 Oct 21;58(10):1502. doi: 10.3390/medicina58101502.
4
Role of Direct Oral Anticoagulants for Post-operative Venous Thromboembolism Prophylaxis.直接口服抗凝剂在术后静脉血栓栓塞预防中的作用。
Eur Cardiol. 2022 May 13;17:e11. doi: 10.15420/ecr.2021.55. eCollection 2022 Feb.
5
Thrombotic activation before and after total hip arthroplasty. A prospective cohort study.全髋关节置换术前和术后的血栓形成激活。一项前瞻性队列研究。
BMC Musculoskelet Disord. 2021 Aug 13;22(1):691. doi: 10.1186/s12891-021-04566-1.
6
Interrelationship of MMP-9, Proteoglycan-4, and Inflammation in Osteoarthritis Patients Undergoing Total Hip Arthroplasty.在接受全髋关节置换术的骨关节炎患者中,MMP-9、蛋白聚糖-4 和炎症的相互关系。
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:1076029621995569. doi: 10.1177/1076029621995569.
7
An Update on Venous Thromboembolism Rates and Prophylaxis in Hip and Knee Arthroplasty in 2020.2020 年髋关节和膝关节置换术静脉血栓栓塞发生率和预防的最新进展。
Medicina (Kaunas). 2020 Aug 19;56(9):416. doi: 10.3390/medicina56090416.
8
Differential toxicity of processed and non-processed states of CoCrMo degradation products generated from a hip simulator on neural cells.钴铬钼降解产物的加工态和非加工态对神经细胞的毒性差异。该降解产物由髋关节模拟器产生。
Nanotoxicology. 2018 Nov;12(9):941-956. doi: 10.1080/17435390.2018.1498929. Epub 2018 Sep 25.
9
Synthesis and biocompatibility of an argatroban-modified polysulfone membrane that directly inhibits thrombosis.一种直接抑制血栓形成的阿加曲班修饰的聚砜膜的合成及生物相容性。
J Mater Sci Mater Med. 2018 May 9;29(5):66. doi: 10.1007/s10856-018-6054-4.
10
Systemic and local toxicity of metal debris released from hip prostheses: A review of experimental approaches.髋关节假体释放的金属碎屑的全身和局部毒性:实验方法的综述。
Nanomedicine. 2018 Apr;14(3):951-963. doi: 10.1016/j.nano.2018.01.001. Epub 2018 Jan 12.

本文引用的文献

1
The Efficacy Comparison of Tranexamic Acid for Reducing Blood Loss in Total Knee Arthroplasty at Different Dosage Time.氨甲环酸在不同给药时间用于减少全膝关节置换术中失血的疗效比较
J Arthroplasty. 2017 Jan;32(1):33-36. doi: 10.1016/j.arth.2016.06.021. Epub 2016 Jun 22.
2
Fibrinolytic Dysregulation in Total Joint Arthroplasty Patients: Potential Clinical Implications.全关节置换术患者的纤维蛋白溶解失调:潜在的临床意义。
Clin Appl Thromb Hemost. 2016 May;22(4):372-6. doi: 10.1177/1076029615597060. Epub 2015 Jul 22.
3
The incidence of pulmonary embolism and deep vein thrombosis and their predictive risk factors after lower extremity arthroplasty: a retrospective analysis based on diagnosis using multidetector CT.下肢关节置换术后肺栓塞和深静脉血栓形成的发生率及其预测危险因素:基于多排CT诊断的回顾性分析
J Anesth. 2015 Apr;29(2):235-41. doi: 10.1007/s00540-014-1891-x. Epub 2014 Aug 6.
4
Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trial.阿司匹林与低分子肝素用于全髋关节置换术后延长静脉血栓栓塞预防:一项随机试验。
Ann Intern Med. 2013 Jun 4;158(11):800-6. doi: 10.7326/0003-4819-158-11-201306040-00004.
5
Tissue factor-bearing microparticles and thrombus formation.携带组织因子的微粒与血栓形成。
Arterioscler Thromb Vasc Biol. 2011 Apr;31(4):728-33. doi: 10.1161/ATVBAHA.109.200964. Epub 2011 Jan 20.
6
The role of TFPI in regulation of TF-induced thrombogenicity on the surface of human monocytes.组织因子途径抑制物(TFPI)在调节人单核细胞表面 TF 诱导的血栓形成活性中的作用。
Thromb Res. 2010 Nov;126(5):418-25. doi: 10.1016/j.thromres.2010.07.014. Epub 2010 Aug 17.
7
Epidemiology of osteoarthritis.骨关节炎的流行病学。
Clin Geriatr Med. 2010 Aug;26(3):355-69. doi: 10.1016/j.cger.2010.03.001.
8
Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty.利伐沙班与依诺肝素用于髋关节置换术后的血栓预防
N Engl J Med. 2008 Jun 26;358(26):2765-75. doi: 10.1056/NEJMoa0800374.
9
Altered regulation of in-vivo coagulation in orthopedic patients prior to knee or hip replacement surgery.
Blood Coagul Fibrinolysis. 2007 Apr;18(3):219-25. doi: 10.1097/01.mbc.0000264704.90039.5d.
10
Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030.2005年至2030年美国初次和翻修髋关节与膝关节置换术的预测。
J Bone Joint Surg Am. 2007 Apr;89(4):780-5. doi: 10.2106/JBJS.F.00222.